Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA)
J Eur Acad Dermatol Venereol
.
2024 Jan;38(1):e59-e62.
doi: 10.1111/jdv.19432.
Epub 2023 Aug 23.
Authors
J J Pereyra-Rodríguez
1
,
J L Poveda
2
,
A Rivero
3
,
E Serra-Baldrich
4
,
J F Silvestre
5
,
J C Armario-Hita
6
,
M Á Calleja
7
,
J M Carrascosa
8
,
Á Flórez
9
,
P Herranz
10
,
M Comellas
11
,
F J Ortiz de Frutos
12
Affiliations
1
Dermatology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
2
Pharmacy Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
3
Independent Consultant Agustin Rivero, Madrid, Spain.
4
Dermatology Department, Hospital de la Santa Creu i Sant Pau, Universitat Autónoma, Barcelona, Spain.
5
Dermatology Department, Hospital General Universitario Dr Balmis-ISABIAL-UMH, Alicante, Spain.
6
Dermatology Department, Hospital Universitario de Puerto Real, University of Cádiz, Cádiz, Spain.
7
Pharmacy Department, Hospital Universitario Virgen Macarena, Sevilla, Spain.
8
Dermatology Department, Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona, Barcelona, Spain.
9
Dermatology Department, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Spain.
10
Dermatology Department, Hospital Universitario La Paz, Madrid, Spain.
11
Outcomes Research Department, Outcomes'10, Castellón de la Plana, Spain.
12
Dermatology Department, Hospital Universitario 12 Octubre, Madrid, Spain.
PMID:
37594914
DOI:
10.1111/jdv.19432
No abstract available
Publication types
Letter
MeSH terms
Decision Making
Decision Support Techniques
Dermatitis, Atopic* / drug therapy
Humans
Grants and funding
Galderma